USANA Health Sciences (USNA) Reports Q3 Loss, Lags Revenue Estimates

Vaxart to Host Stockholder Fireside Chat on November 6 at 4:30 p.m. ET

A day after Vaxart plans to report results, managers will answer stockholder questions

A 78,800-share stock grant joins director Bono’s 157,400 stock options at Vaxart (VXRT).

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model

Vaxart Announces Publication Of Preclinical Study Results Evaluating Its Oral Mucosal Vaccine Platform Against Highly Pathogenic Avian Influenza H5N1; Candidate VXA-H5-02 Induced Robust Cross-Neutralizing Antibodies

Vaxart Highlights Oral Vaccine Platform, COVID Trial Progress at H.C. Wainwright Conference

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology

Vaxart Inc (VXRT) (Q2 2026) Earnings Call Highlights: Oral COVID Vaccine Shows Promise, Cash ...

Vaxart Q2 Earnings Call Highlights

VXRT Forecast — Price Target — Prediction for 2027

VAXART ($VXRT) Releases Q4 2025 Earnings

Is Vaxart's (VXRT) Conference Spotlight Reframing the Oral Vaccine Story or Just Polishing It?